LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 1 of 15: Cell count and relative growth within biological replicate 1. - Dataset (ID:20237)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Replicate | Assay Well | Timepoint | Timepoint Unit | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Relative Growth Rate After Treatment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SK-BR-3 | Geldanamycin | 10.0 | uM | LJP5 | 1 | O01 | 72 | hr | 1476 | 451 | 3694 | 0.1221 | -0.4626 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP6 | 3 | C19 | 72 | hr | 1476 | 455 | 3694 | 0.1232 | -0.4608 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP6 | 1 | C19 | 72 | hr | 1476 | 540 | 3694 | 0.1462 | -0.4225 |
| SK-BR-3 | LDN-193189 | 10.0 | uM | LJP5 | 1 | G01 | 72 | hr | 1476 | 555 | 3694 | 0.1502 | -0.4157 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP5 | 2 | C19 | 72 | hr | 1476 | 555 | 3694 | 0.1502 | -0.4157 |
| SK-BR-3 | QL-XII-47 | 10.0 | uM | LJP6 | 1 | O19 | 72 | hr | 1476 | 601 | 3694 | 0.1627 | -0.3949 |
| SK-BR-3 | GSK1059615 | 10.0 | uM | LJP5 | 1 | E01 | 72 | hr | 1476 | 609 | 3694 | 0.1649 | -0.3913 |
| SK-BR-3 | CGP60474 | 10.0 | uM | LJP6 | 3 | G01 | 72 | hr | 1476 | 610 | 3694 | 0.1651 | -0.3909 |
| SK-BR-3 | QL-XII-47 | 10.0 | uM | LJP6 | 2 | O19 | 72 | hr | 1476 | 630 | 3694 | 0.1705 | -0.3819 |
| SK-BR-3 | Geldanamycin | 10.0 | uM | LJP5 | 2 | O01 | 72 | hr | 1476 | 630 | 3694 | 0.1705 | -0.3819 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP6 | 2 | C19 | 72 | hr | 1476 | 639 | 3694 | 0.1730 | -0.3778 |
| SK-BR-3 | Geldanamycin | 10.0 | uM | LJP6 | 1 | O01 | 72 | hr | 1476 | 639 | 3694 | 0.1730 | -0.3778 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP5 | 3 | C19 | 72 | hr | 1476 | 640 | 3694 | 0.1733 | -0.3774 |
| SK-BR-3 | Geldanamycin | 10.0 | uM | LJP6 | 3 | O01 | 72 | hr | 1476 | 664 | 3694 | 0.1798 | -0.3665 |
| SK-BR-3 | CGP60474 | 10.0 | uM | LJP5 | 1 | F01 | 72 | hr | 1476 | 686 | 3694 | 0.1857 | -0.3566 |
| SK-BR-3 | AT-7519 | 10.0 | uM | LJP6 | 2 | K01 | 72 | hr | 1476 | 691 | 3694 | 0.1871 | -0.3544 |
| SK-BR-3 | LDN-193189 | 10.0 | uM | LJP5 | 3 | G01 | 72 | hr | 1476 | 692 | 3694 | 0.1873 | -0.3539 |
| SK-BR-3 | Mitoxantrone | 10.0 | uM | LJP5 | 1 | C19 | 72 | hr | 1476 | 697 | 3694 | 0.1887 | -0.3517 |
| SK-BR-3 | HG-6-64-01 | 10.0 | uM | LJP6 | 3 | M01 | 72 | hr | 1476 | 698 | 3694 | 0.1890 | -0.3512 |
| SK-BR-3 | AT-7519 | 10.0 | uM | LJP6 | 3 | K01 | 72 | hr | 1476 | 699 | 3694 | 0.1892 | -0.3508 |
| SK-BR-3 | AZD 5438 | 10.0 | uM | LJP6 | 1 | J01 | 72 | hr | 1476 | 700 | 3694 | 0.1895 | -0.3503 |
| SK-BR-3 | Omipalisib | 10.0 | uM | LJP6 | 1 | N01 | 72 | hr | 1476 | 702 | 3694 | 0.1900 | -0.3494 |
| SK-BR-3 | Geldanamycin | 10.0 | uM | LJP5 | 3 | O01 | 72 | hr | 1476 | 710 | 3694 | 0.1922 | -0.3458 |
| SK-BR-3 | AZD7762 | 10.0 | uM | LJP6 | 1 | L01 | 72 | hr | 1476 | 712 | 3694 | 0.1927 | -0.3449 |
| SK-BR-3 | Alvocidib | 10.0 | uM | LJP6 | 3 | A13 | 72 | hr | 1476 | 716 | 3694 | 0.1938 | -0.3431 |